Ventas, Inc. filings document the regulatory record of a healthcare real estate investment trust whose common stock trades on the New York Stock Exchange under VTR. The company’s disclosures include Form 8-K reports for operating results, quarterly and annual earnings releases, dividend-related events, material financing agreements and capital markets activity.
Recent filings also cover amendments to credit facilities, registered senior notes issued by Ventas Realty, Limited Partnership and guaranteed by Ventas, ATM sales agreement updates, officer-transition disclosures and proxy materials addressing director elections, executive compensation, shareholder voting matters and governance.
Ventas, Inc. amended its at-the-market equity program, increasing the aggregate gross sales price of common stock available for issuance under its Sales Agreement to $3,000,000,000, excluding shares previously sold. This allows the company to issue or sell additional shares through multiple agents and forward purchasers under an existing shelf registration.
The company also entered into a separation and release agreement with executive Peter J. Bulgarelli tied to his May 1, 2026 retirement, providing a prorated 2026 bonus in exchange for a release of claims and covenant compliance. At the 2026 Annual Meeting, all 12 director nominees were elected, executive compensation was approved on an advisory basis, and KPMG LLP was ratified as auditor with strong shareholder support.
Smith Maurice S reported acquisition or exercise transactions in this Form 4 filing.
Ventas, Inc. director Maurice S. Smith received an award of 2,047 shares of common stock in the form of restricted stock units, valued at $90.35 per share on the grant date. These units were granted under the Ventas, Inc. 2022 Incentive Plan as part of director compensation.
The restricted stock units vest on the earlier of the one-year anniversary of the grant date or the date of the company’s 2027 Annual Meeting of Stockholders. After this grant, Smith directly holds a total of 30,722.671 shares of Ventas common stock.
Roy Sumit reported acquisition or exercise transactions in this Form 4 filing.
Ventas, Inc. director Sumit Roy received a grant of 2,047 shares of common stock as restricted stock units under the Ventas, Inc. 2022 Incentive Plan. The award is valued at $90.35 per share, based on the closing price on the grant date, and will vest on the earlier of one year from grant or the company’s 2027 Annual Meeting of Stockholders. Following this compensation-related grant, Roy directly holds 24,404.224 shares of Ventas common stock.
Rodriguez Joe Vasquez Jr. reported acquisition or exercise transactions in this Form 4 filing.
Ventas, Inc. director Rodriguez Joe Vasquez Jr. reported an equity award of 2,047 restricted stock units of common stock. The units were granted pursuant to the Ventas, Inc. 2022 Incentive Plan and were valued using the $90.35 closing share price on the grant date.
The restricted stock units vest on the earlier of the one-year anniversary of the grant date or the date of Ventas, Inc.'s 2027 Annual Meeting of Stockholders. Following this grant, Rodriguez Joe Vasquez Jr. holds a total of 9,894.719 shares of Ventas common stock directly.
Ventas, Inc. director Walter C. Rakowich reported two recent transactions in the company’s common stock. On May 13, 2026, he acquired 2,047 restricted stock units under the Ventas, Inc. 2022 Incentive Plan at a reference price of $90.35 per share. These units vest on the earlier of one year from the grant date or the company’s 2027 annual stockholders’ meeting. On May 14, 2026, he completed an open-market sale of 1,152 shares at a weighted average price of about $90.20 per share, executed under a pre-established Rule 10b5-1 trading plan and across trades ranging from $90.00 to $90.83. After these transactions, he directly holds 28,349 shares of Ventas common stock.
Nolan Sean P. reported acquisition or exercise transactions in this Form 4 filing.
Ventas, Inc. director Sean P. Nolan received a grant of 2,047 shares of common stock in the form of restricted stock units, treated at a reference price of $90.35 per share. These units were granted under the Ventas, Inc. 2022 Incentive Plan and vest on the earlier of the one-year anniversary of the grant date or the company’s 2027 Annual Meeting of Stockholders. After this award, Nolan directly holds 26,181 shares of Ventas common stock.
NADER MARGUERITE M reported acquisition or exercise transactions in this Form 4 filing.
Ventas, Inc. director Marguerite M. Nader received a grant of 2,047 shares of common stock in the form of restricted stock units at a reference price of $90.35 per share under the Ventas, Inc. 2022 Incentive Plan. These restricted stock units vest on the earlier of the one-year anniversary of the grant date or the date of Ventas’s 2027 Annual Meeting of Stockholders. Following this equity award, Nader directly holds 23,471.958 shares of Ventas common stock.
Martino Roxanne M reported acquisition or exercise transactions in this Form 4 filing.
Ventas, Inc. director Roxanne M. Martino received a grant of 2,047 shares of common stock in the form of restricted stock units under the Ventas, Inc. 2022 Incentive Plan. These units vest on the earlier of the one-year anniversary of the grant date or the date of Ventas' 2027 Annual Meeting of Stockholders.
After this award, Martino directly holds a total of 66,128.021 shares of Ventas common stock. The grant price reference for the award was the closing price of $90.35 per share on the grant date.
LUSTIG MATTHEW J reported acquisition or exercise transactions in this Form 4 filing.
Ventas, Inc. director Matthew J. Lustig received an equity grant of 2,047 shares of common stock, reported as restricted stock units, valued at $90.35 per share based on the grant-date closing price. Following this award, he directly holds 95,005.712 shares of Ventas common stock.
The restricted stock units were granted under the Ventas, Inc. 2022 Incentive Plan and will vest on the earlier of the one-year anniversary of the grant date or the date of Ventas' 2027 Annual Meeting of Stockholders, tying the award to ongoing board service.
EMBLER MICHAEL J reported acquisition or exercise transactions in this Form 4 filing.
Ventas, Inc. director Michael J. Embler received a grant of 2,047 restricted stock units of common stock, valued at $90.35 per share based on the grant-date closing price. These units vest on the earlier of one year from grant or the company’s 2027 Annual Meeting of Stockholders, bringing his direct holdings to 16,701.958 shares.